These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30761959)

  • 1. Higher Anti-angiogenesis Activity, Better Cellular Uptake and Longer Half-life of a Novel Glyco-modified Endostatin by Polysulfated Heparin.
    Sun F; Shaikh AS; Wang J; Gao H; Yang Z; Wang Z; Li Y; Wang F; Tan H
    Curr Pharm Biotechnol; 2018; 19(12):996-1004. PubMed ID: 30761959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization and anti-angiogenesis activity of endostatin covalently modified by polysulfated heparin.
    Ning TH; Chao CJ; Ying MG; Min X; Shan WF
    Pharmazie; 2012 Jul; 67(7):622-7. PubMed ID: 22888520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor make low molecular weight heparin-endostatin and polyethylene glycol-endostatin potential candidates for anti-angiogenesis drug.
    Tan H; Mu G; Zhu W; Liu J; Wang F
    Biol Pharm Bull; 2011; 34(4):545-50. PubMed ID: 21467643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization, bioactivity and pharmacokinetic study of a novel carbohydrate-peptide polymer: Glycol-split heparin-endostatin2 (GSHP-ES2).
    Sun F; Wang Z; Yang Z; Li Y; Cui H; Liu C; Gao D; Wang F; Tan H
    Carbohydr Polym; 2019 Mar; 207():79-90. PubMed ID: 30600066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin.
    Tan H; Yang S; Liu C; Cao J; Mu G; Wang F
    Biomed Pharmacother; 2012 Dec; 66(8):648-54. PubMed ID: 23122594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented anti-angiogenesis activity of polysulfated heparin-endostatin and polyethylene glycol-endostatin in alkali burn-induced corneal ulcers in rabbits.
    Li ZN; Yuan ZF; Mu GY; Hu M; Cao LJ; Zhang YL; Ge MX
    Exp Ther Med; 2015 Sep; 10(3):889-894. PubMed ID: 26622410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on glyco-modification of endostatin-derived synthetic peptide endostatin2 (ES2) by soluble chitooligosaccharide.
    Yu Y; Sun F; Zhang C; Wang Z; Liu J; Tan H
    Carbohydr Polym; 2016 Dec; 154():204-13. PubMed ID: 27577911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and secondary structure analysis of endostatin covalently modified by polyethylene glycol and low molecular weight heparin.
    Tan H; Yang S; Feng Y; Liu C; Cao J; Mu G; Wang F
    J Biochem; 2008 Aug; 144(2):207-13. PubMed ID: 18463113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endostatin derivative angiogenesis inhibitors.
    Zheng MJ
    Chin Med J (Engl); 2009 Aug; 122(16):1947-51. PubMed ID: 19781376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of polysulfated heparin endostatin on alkali burn induced corneal neovascularization in rabbits.
    Li ZN; Yuan ZF; Mu GY; Hu M; Cao LJ; Zhang YL; Liu L; Ge MX
    Int J Ophthalmol; 2015; 8(2):234-8. PubMed ID: 25938033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tat PTD-endostatin: A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops.
    Zhang X; Li Y; Cheng Y; Tan H; Li Z; Qu Y; Mu G; Wang F
    Biochim Biophys Acta; 2015 Jun; 1850(6):1140-9. PubMed ID: 25662072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intracellular protein delivery on the anti-tumor activity of recombinant human endostatin.
    Lim J; Duong T; Lee G; Seong BL; El-Rifai W; Ruley HE; Jo D
    Biomaterials; 2013 Aug; 34(26):6261-71. PubMed ID: 23714245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering of a disulfide loop instead of a Zn binding loop restores the anti-proliferative, anti-angiogenic and anti-tumor activities of the N-terminal fragment of endostatin: Mechanistic and therapeutic insights.
    Chamani R; Asghari SM; Alizadeh AM; Eskandari S; Mansouri K; Khodarahmi R; Taghdir M; Heidari Z; Gorji A; Aliakbar A; Ranjbar B; Khajeh K
    Vascul Pharmacol; 2015 Sep; 72():73-82. PubMed ID: 26187352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
    Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiangiogenic and antitumor activities of the N-terminal fragment of endostatin augmented by Ile/Arg substitution: The overall structure implicated the biological activity.
    Chamani R; Asghari SM; Alizadeh AM; Mansouri K; Doroudi T; Kolivand PH; Ghafouri H; Ehtesham S; Rabouti H; Mehrnejad F
    Biochim Biophys Acta; 2016 Dec; 1864(12):1765-1774. PubMed ID: 27693049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor effect of local injectable hydrogel-loaded endostatin alone and in combination with radiotherapy for lung cancer.
    Wang N; Gao Q; Tang J; Jiang Y; Yang L; Shi X; Chen Y; Zhang Y; Fu S; Lin S
    Drug Deliv; 2021 Dec; 28(1):183-194. PubMed ID: 33427520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid.
    Alam F; Al-Hilal TA; Chung SW; Seo D; Mahmud F; Kim HS; Kim SY; Byun Y
    Biomaterials; 2014 Aug; 35(24):6543-52. PubMed ID: 24816287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of RGD-4C position is more important than disulfide bonds on antiangiogenic activity of RGD-4C modified endostatin derived synthetic polypeptide.
    Yin R; Zheng H; Xi T; Xu HM
    Bioconjug Chem; 2010 Jul; 21(7):1142-7. PubMed ID: 20515045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies.
    Tee D; DiStefano J
    J Cancer Res Clin Oncol; 2004 Jan; 130(1):15-24. PubMed ID: 14586644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.